Company Kelyniam Global, Inc. Other OTC
Equities
KLYG
US4883591004
Advanced Medical Equipment & Technology
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Custom Prosthetic Cranial Implants
100.0
%
| 3 | 100.0 % | 3 | 100.0 % | -11.44% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 3 | 100.0 % | 3 | 100.0 % | -11.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ross Bjella
CEO | Chief Executive Officer | - | 08/01/18 |
Director of Finance/CFO | - | 31/01/20 | |
Chief Operating Officer | - | 31/12/10 | |
Desiree Webb
BRD | Director/Board Member | - | - |
Mark V. Smith
PRN | Corporate Officer/Principal | - | 31/05/14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Operating Officer | - | 31/12/10 | |
Mark V. Smith
PRN | Corporate Officer/Principal | - | 31/05/14 |
Ross Bjella
CEO | Chief Executive Officer | - | 08/01/18 |
Desiree Webb
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,923,145 | 16,022,500 ( 53.55 %) | 0 | 53.55 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+12.85% | 227B | |
+13.88% | 192B | |
+18.39% | 136B | |
+28.78% | 108B | |
+1.67% | 64.07B | |
+18.24% | 52.1B | |
+7.04% | 51.87B | |
+10.83% | 44.33B | |
+5.94% | 36.75B |